Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress

Media ReleaseCOPENHAGEN, Denmark; May 25, 2023 Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide in high-risk follicular lymphomaPoster presentations... | May 25, 2023

Related Keywords

Japan ,United States ,New Jersey ,Germany ,Copenhagen ,Køavn ,Denmark ,Tokyo ,Lugano ,Ticino ,Switzerland ,Netherlands ,Chicago ,Illinois ,American ,Judith Klimovsky ,David Freundel ,Andrew Carlsen ,Kalvebod Brygge ,Twitter ,American Society Of Clinical Oncology ,Meeting Library ,Product Communications ,Exchange Commission ,Access Library ,Ministry Of Health ,Abbvie Biotechnology Ltd ,European Medicines Agency ,International Conference On Malignant Lymphoma ,European Hematology Association ,Clinical Oncology ,Annual Meeting ,Hematology Association ,Executive Vice President ,Chief Development Officer ,International Conference ,Malignant Lymphoma ,World Evidence ,Marketing Authorization Application ,European Medicines ,Release Syndrome ,Effector Cell ,Associated Neurotoxicity Syndrome ,Prescribing Information ,Medication Guide ,Senior Director ,Vice President ,Media Release ,Annual Report ,Y Shaped Genmab ,Abbvie Biotechnology ,Genmabas Stock Exchange ,News ,Information ,Press Release ,Media ,Bay ,023 ,Mural ,Presentations ,Hill ,Highlight ,N ,Combination ,Ith ,Follicular ,Ymphomaposter Gmab Dk0010272202 ,